Sex-Specific Protection of Osteoarthritis by Deleting Cartilage Acid Protein 1

Cartilage acidic protein 1 (CRTAC1) was recently identified as an elevated protein in the synovial fluid of patients with osteoarthritis (OA) by a proteomic analysis. This gene is also upregulated in both human and mouse OA by transcriptomic analysis. The objective of this study was to characterize...

Full description

Saved in:
Bibliographic Details
Published inPloS one Vol. 11; no. 7; p. e0159157
Main Authors Ge, Xianpeng, Ritter, Susan Y., Tsang, Kelly, Shi, Ruirui, Takei, Kohtaro, Aliprantis, Antonios O.
Format Journal Article
LanguageEnglish
Published United States Public Library of Science 14.07.2016
Public Library of Science (PLoS)
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Cartilage acidic protein 1 (CRTAC1) was recently identified as an elevated protein in the synovial fluid of patients with osteoarthritis (OA) by a proteomic analysis. This gene is also upregulated in both human and mouse OA by transcriptomic analysis. The objective of this study was to characterize the expression and function of CRTAC1 in OA. Here, we first confirm the increase of CRTAC1 in cartilage biopsies from OA patients undergoing joint replacement by real-time PCR and immunohistochemistry. Furthermore, we report that proinflammatory cytokines interleukin-1beta and tumor necrosis factor alpha upregulate CRTAC1 expression in primary human articular chondrocytes and synovial fibroblasts. Genetic deletion of Crtac1 in mice significantly inhibited cartilage degradation, osteophyte formation and gait abnormalities of post-traumatic OA in female, but not male, animals undergoing the destabilization of medial meniscus (DMM) surgery. Taken together, CRTAC1 is upregulated in the osteoarthritic joint and directly induced in chondrocytes and synovial fibroblasts by pro-inflammatory cytokines. This molecule is necessary for the progression of OA in female mice after DMM surgery and thus represents a potential therapy for this prevalent disease, especially for women who demonstrate higher rates and more severe OA.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
Competing Interests: The authors have declared that no competing interests exist.
Current address: Department of Orthopaedics and Rehabilitation, Yale University School of Medicine, New Haven, Connecticut, United States of America
Conceived and designed the experiments: AOA XG. Performed the experiments: XG SYR K. Tsang. Analyzed the data: XG RS AOA. Contributed reagents/materials/analysis tools: K. Takei. Wrote the paper: XG AOA.
Current address: Merck Research Laboratories, 33 Avenue Louis Pasteur, Boston, Massachusetts, United States of America
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0159157